2-85560218-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000821.7(GGCX):​c.214+597G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.409 in 151,940 control chromosomes in the GnomAD database, including 12,874 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 12874 hom., cov: 31)

Consequence

GGCX
NM_000821.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00400

Publications

39 publications found
Variant links:
Genes affected
GGCX (HGNC:4247): (gamma-glutamyl carboxylase) This gene encodes an integral membrane protein of the rough endoplasmic reticulum that carboxylates glutamate residues of vitamin K-dependent proteins to gamma carboxyl glutamate, a modification that is required for their activity. The vitamin K-dependent protein substrates have a propeptide that binds the enzyme, with carbon dioxide, dioxide, and reduced vitamin K acting as co-substrates. Vitamin K-dependent proteins affect a number of physiologic processes including blood coagulation, prevention of vascular calcification, and inflammation. Allelic variants of this gene have been associated with pseudoxanthoma elasticum-like disorder with associated multiple coagulation factor deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
GGCX Gene-Disease associations (from GenCC):
  • body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • vitamin K-dependent clotting factors, combined deficiency of, type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • pulmonary arterial hypertension
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.462 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000821.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GGCX
NM_000821.7
MANE Select
c.214+597G>A
intron
N/ANP_000812.2
GGCX
NM_001142269.4
c.44-1143G>A
intron
N/ANP_001135741.1P38435-2
GGCX
NM_001311312.2
c.214+597G>A
intron
N/ANP_001298241.1A0A8I5QJA4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GGCX
ENST00000233838.9
TSL:1 MANE Select
c.214+597G>A
intron
N/AENSP00000233838.3P38435-1
GGCX
ENST00000423570.5
TSL:1
n.259+597G>A
intron
N/A
GGCX
ENST00000911478.1
c.214+597G>A
intron
N/AENSP00000581537.1

Frequencies

GnomAD3 genomes
AF:
0.409
AC:
62043
AN:
151822
Hom.:
12859
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.468
Gnomad AMI
AF:
0.443
Gnomad AMR
AF:
0.340
Gnomad ASJ
AF:
0.342
Gnomad EAS
AF:
0.386
Gnomad SAS
AF:
0.353
Gnomad FIN
AF:
0.401
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.399
Gnomad OTH
AF:
0.399
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.409
AC:
62091
AN:
151940
Hom.:
12874
Cov.:
31
AF XY:
0.407
AC XY:
30246
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.467
AC:
19351
AN:
41406
American (AMR)
AF:
0.340
AC:
5193
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
1186
AN:
3472
East Asian (EAS)
AF:
0.385
AC:
1996
AN:
5178
South Asian (SAS)
AF:
0.353
AC:
1697
AN:
4808
European-Finnish (FIN)
AF:
0.401
AC:
4224
AN:
10540
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.399
AC:
27099
AN:
67940
Other (OTH)
AF:
0.402
AC:
848
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1852
3704
5555
7407
9259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.403
Hom.:
24568
Bravo
AF:
0.408
Asia WGS
AF:
0.401
AC:
1392
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.7
DANN
Benign
0.68
PhyloP100
-0.0040
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12714145; hg19: chr2-85787341; API